Vibalogics is a privately-owned contract development and manufacturing organization (CDMO) offering process development, manufacturing, testing, and fill-finish services to innovators developing revolutionary virotherapy products.

We are currently doubling the current capacity of suspension-based virus manufacturing with a new 500 liter production line in building 6 and we are adding the new building 8 with locker and change rooms.

One 500 L production line in building 6 consisting of:
– 400m2 production area
– 2 x expansion suites (BSL-1, ISO 7-8, class C)
– 2 x USP / DSP suites (BSL-2, ISO 7-8, class C)
– Solution feed
– 16 dedicated FTE
– Plan to expand capacity by >20x500L batches/year (2023)
– 2022 expected capacity 14 batches/year